Find Federal Grants
Bureau of Justice Assistance · BJA-2019-16313
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
National Institutes of Health · PAR-19-327
OSERS-OSEP: Educational Technology, Media, and Materials for Individuals with Disabilities: National Center on Accessible Educational Materials for Learning CFDA Number 84.327Z
Department of Education · ED-GRANTS-080119-001
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional)
National Institutes of Health · PAR-19-326
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trials Optional)
National Institutes of Health · RFA-CA-19-063
National Institutes of Health · PAR-19-321
USAID Scholars Activity
Egypt USAID-Cairo · 72026319RFA00003
Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
National Institutes of Health · RFA-ES-19-011
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)
National Institutes of Health · RFA-CA-19-061
Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)
National Institutes of Health · RFA-CA-19-062
The Liberia Youth Activity
Liberia USAID-Monrovia · RFI-LIBYOUTH-LIBERIA
National Institutes of Health · PAR-19-320
U.S. Mission to Morocco · PAS-MOROCCO-FY19-05
National Park Service · NPS-19-NERO-0086
National Park Service · P19AS00442
Arctic Youth Entrepreneurship
U.S. Mission to Norway · DOS-OSLO-PAS-NOFO-FY20-3
National Park Service · P19AS00447
National Park Service · P19AS00446
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
National Institutes of Health · PAR-19-325
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-19-046